Picture of Horizon Therapeutics logo

HZNP Horizon Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge Cap

Annual balance sheet for Horizon Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:10-Q10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments9591,0762,0801,5802,353
Net Total Accounts Receivable
Net Total Receivables465409660633676
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets1,5461,6863,0702,8003,653
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment20.170223368440
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets3,9424,4366,0738,6789,115
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities709723876887949
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities2,7522,2512,0474,0054,042
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity1,1902,1854,0254,6725,072
Total Liabilities & Shareholders' Equity3,9424,4366,0738,6789,115
Total Common Shares Outstanding